3D Cell Culture Market to Reach USD 1,846 Million in 2024 – Size, Share, Growth, Emerging Trends, Top 10 Players and Industry Outlook


“The major players in the 3D cell culture market are Thermo Fisher Scientific (US), Corning Incorporated (US), Merck KGaA (Germany), Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany ), InSphero (Switzerland), Synthecon (US), 3D Biotek (US), CN Bio (UK), Hamilton Company (US), MIMETAS (Netherlands), Emulate (US ).

The 3D Cell Culture Market research report gives a detailed analysis of the industry segments, opportunities, growth and size.

The global 3D cell culture market size is expected to reach USD 1,846 million in 2024, from USD 892 million in 2019, at a CAGR of 15.7%. The growth of this market is mainly due to the increasing focus on the development of alternatives to animal testing, the growing focus on personalized medicine, the increasing incidence of chronic diseases and the availability of research funding. On the other hand, lack of infrastructure for 3D cell research and high cost of cell biology research is expected to restrain the growth of this market over the forecast period.

The study involved four major activities in estimating the current size of the global 3D Cell Culture market. Extensive secondary research was carried out to collect information about the market, its peer markets and its parent market. The next step was to validate these results, assumptions and sizing values ​​with industry experts across the value chain through primary research. Both top-down and bottom-up approaches have been used to estimate the full market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and sub-segments.

Download the PDF brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847

The 3D cell culture on scaffold segment accounted for the largest share of the 3D cell culture market in 2018

On the basis of product, the market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic and bio-printed 3D cell cultures. Scaffold-based 3D cell cultures accounted for the largest market share in 2018. The advantages of scaffolds in 3D cell culture, such as structural rigidity and availability of attachment points, strongly drove the preference for cultures scaffold-based 3D cells and provided the bulk of this segment.

The pharmaceutical and biotechnology companies segment accounted for the largest end-user market share in 2018

Based on end user, the market is segmented into pharmaceutical and biotechnology companies, research institutes, cosmetics industry, and other end users. Pharmaceutical and biotechnology companies accounted for the largest share of the market in 2018. The presence of a large number of pharmaceutical and biotechnology companies, an increase in R&D expenditure in these companies, and the growing preference for alternative test models over animal techniques are the key. market drivers in this end-user segment.

Market Size Estimate:

Both top-down and bottom-up approaches have been used to estimate and validate the total market size of the Global 3D Cell Culture Market. These methods have also been widely used to estimate the size of various market sub-segments. The research methodology used to estimate the market size includes the following:

  • Key industry and market players have been identified through extensive secondary research.
  • The revenue generated from the sale of 3D Cell Culture Products by the major players has been determined by primary and secondary research.
  • All shares, breakdowns and percentage breakdowns have been determined using secondary sources and verified using primary sources.

North America held the largest market share owing to the rising incidence of cancer and the presence of a well-established pharmaceutical and biotechnology industry. However, the market in Europe is expected to grow at the highest CAGR over the forecast period. The growth of the market in Europe is attributed to the growth of its pharmaceutical and biotechnology industry, the recent commercialization of microfluidics-based products, the growing presence of major players in the market and a large number of research activities carried out In the region.

Request sample pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=191072847

Thermo Fisher Scientific (USA), Corning Incorporated (USA), Merck KGaA (Germany), Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany), InSphero (Switzerland), Synthecon (USA ), 3D Biotek (USA), CN Bio (UK), Hamilton Company (USA), MIMETAS (Netherlands), Emulate (USA), Hµrel Corporation (USA), QGel SA (Switzerland), SynVivo (United States), Advanced BioMatrix (United States), Greiner Bio-One International (Austria) and PromoCell (Germany).

Media Contact
Company Name: MarketsandMarkets
Contact person: Mr. Aashish Mehra
E-mail: Send an email
Call: 18886006441
Address:630 Dundee Road, Suite 430
City: Northbrook
State: IT 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html


Source link

Previous From chickpea omelet to lemon corn cookies: our eight best vegan recipes of the day!
Next 10 classic whiskey cocktail recipes to elevate your home bar repertoire